top of page

Interphex
Tue, Apr 01
|Javits Center - Stage 2
Cell and gene therapy product manufacturing is viewed as nonbinding for the Annex 1 guidance for sterile manufacturing. The elephant in the room on the topic of Contamination Control Strategy (CCS) is "Do you need to create a CCS if you are in cell and/or gene therapy manufacturing?"
Registration is closed
See other events


bottom of page